JSC Biocad is a Pioneer
BIOCAD pioneers development of local substances among Russian pharmaceutical manufacturers. It helped organize full cycle of production of drugs for multiple sclerosis, cancer, hepatitis C and HIV infection
According to Dmitry Morozov, General Director of BIOCAD, a biotechnological company, production of locally manufactured substances provides an opportunity of full cycle of manufacture of 20 products, including 15 innovative drugs. The project includes drugs for treatment of cancers, hepatitis C, HIV, multiple sclerosis and other pathologies. Own production of chemical substances and manufacture of complex drugs not only provide import substitution in Russia, but also open new prospects for entry to the global pharmaceutical market.
The license issued by the Ministry of Industry and Trade of the Russian Federation confirmed the right of BIOCAD for manufacture of substances and finished product formulations on their basis. The basis for license inspection was to open new production facilities of BIOCAD in Moscow and Saint-Petersburg, equipped and organized in strict compliance with international GMP standards, which is confirmed by the license.